These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21455061)

  • 41. HIV and the body: a review of multidisciplinary management.
    Rockstroh J; Guaraldi G; Deray G
    HIV Med; 2010 Sep; 11 Suppl 2():1-8. PubMed ID: 20929492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiretroviral molecules and cardiovascular diseases.
    Gibellini D; Borderi M; Clò A; Morini S; Miserocchi A; Bon I; Re MC
    New Microbiol; 2012 Oct; 35(4):359-75. PubMed ID: 23109004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complications of Treatment in Youth with HIV.
    Eckard AR; Fowler SL; Haston JC; Dixon TC
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):226-33. PubMed ID: 27234970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal complications in HIV disease: between present and future.
    Maggi P; Bartolozzi D; Bonfanti P; Calza L; Cherubini C; Di Biagio A; Marcotullio S; Montella F; Montinaro V; Mussini C; Narciso P; Rusconi S; Vescini F
    AIDS Rev; 2012; 14(1):37-53. PubMed ID: 22297503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain.
    Knobel H; Domingo P; Suarez-Lozano I; Gutierrez F; Estrada V; Palacios R; Antela A; Blanco JR; Fulladosa X; Refollo E;
    Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(6):373-379. PubMed ID: 30389268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Metabolic bone disorders in HIV patients].
    Reisfeld S; Chowers M
    Harefuah; 2013 Apr; 152(4):238-41, 245. PubMed ID: 23844528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human immunodeficiency virus: what primary care clinicians need to know.
    Burgess MJ; Kasten MJ
    Mayo Clin Proc; 2013 Dec; 88(12):1468-74. PubMed ID: 24290121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What happens to cardiovascular system behind the undetectable level of HIV viremia?
    d'Ettorre G; Ceccarelli G; Pavone P; Vittozzi P; De Girolamo G; Schietroma I; Serafino S; Giustini N; Vullo V
    AIDS Res Ther; 2016; 13():21. PubMed ID: 27127532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opportunistic infections in HIV disease.
    Wingfield T; Wilkins E
    Br J Nurs; 2010 May 27-Jun 9; 19(10):621-7. PubMed ID: 20665998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney disease in the HIV-infected patient.
    Fine DM; Atta MG
    AIDS Patient Care STDS; 2007 Nov; 21(11):813-24. PubMed ID: 18240891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Care of Patients With HIV Infection: Primary Care.
    Bolduc P; Roder N; Colgate E; Cheeseman SH
    FP Essent; 2016 Apr; 443():31-42. PubMed ID: 27092565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complications of HIV disease and antiretroviral treatment.
    Luetkemeyer AF; Havlir DV; Currier JS
    Top HIV Med; 2010; 18(2):57-65. PubMed ID: 20516525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [HIV-associated non-AIDS conditions].
    Hasse B; Bernasconi E; Furrer H; Eyer MM; Kovari H
    Ther Umsch; 2014 Aug; 71(8):483-9. PubMed ID: 25093313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Travel medicine for HIV-infected patients].
    Rossi M; Furrer H
    Ther Umsch; 2001 Jun; 58(6):381-6. PubMed ID: 11441700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular involvements in HIV-infected patients.
    Alharethi R
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1227-35. PubMed ID: 23972010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-related metabolic comorbidities in the current ART era.
    Warriner AH; Burkholder GA; Overton ET
    Infect Dis Clin North Am; 2014 Sep; 28(3):457-76. PubMed ID: 25151566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.
    Lundgren JD; Battegay M; Behrens G; De Wit S; Guaraldi G; Katlama C; Martinez E; Nair D; Powderly WG; Reiss P; Sutinen J; Vigano A;
    HIV Med; 2008 Feb; 9(2):72-81. PubMed ID: 18257770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology and pathogenesis of human immunodeficiency virus (HIV) related heart disease: a review.
    Sani MU; Okeahialam BN
    Niger J Med; 2005; 14(3):255-60. PubMed ID: 16350692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selected issues in the treatment of women infected with HIV.
    Young MA; Clark RA
    Clin Obstet Gynecol; 2001 Jun; 44(2):167-81. PubMed ID: 11344986
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy.
    Tumbarello M; Tacconelli E; de Gaetano Donati K; Cauda R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):208-9. PubMed ID: 10048911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.